Literature DB >> 29119198

[Segmental neurofibromatosis].

G Wagner1, V Meyer2, M M Sachse2.   

Abstract

Thirteen years ago, a 48-year-old man developed numerous neurofibromas in a circumscribed area on the right chest. At the same time, a bilateral seminoma was diagnosed and treated curatively. There was no evidence for other complications of neurofibromatosis. The family history was inconspicuous. The segmental neurofibromatosis (SN) presented in this patient is the result of a mosaic formation resulting from a mutation of the NF1 gene, a tumor suppressor gene. Concomitant, typical diseases of neurofibromatosis generalisata (NFG), including malignant neoplasms, are the exception to SN.

Entities:  

Keywords:  Blaschko’s lines; Cancer; Generalized neurofibromatosis; Mosaicism; Postzygotic mutations

Mesh:

Year:  2018        PMID: 29119198     DOI: 10.1007/s00105-017-4078-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  11 in total

1.  Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).

Authors:  Ludwine Messiaen; Julia Vogt; Kathrin Bengesser; Chuanhua Fu; Fady Mikhail; Eduard Serra; Carles Garcia-Linares; David N Cooper; Conxi Lazaro; Hildegard Kehrer-Sawatzki
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

Review 2.  The clinical and diagnostic implications of mosaicism in the neurofibromatoses.

Authors:  M Ruggieri; S M Huson
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

3.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

Review 4.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

Review 5.  Segmental neurofibromatosis and malignancy.

Authors:  Julie D Dang; Philip R Cohen
Journal:  Skinmed       Date:  2010 May-Jun

Review 6.  Segmental neurofibromatosis: case reports and review.

Authors:  C M Hager; P R Cohen; J A Tschen
Journal:  J Am Acad Dermatol       Date:  1997-11       Impact factor: 11.527

Review 7.  Mosaic Neurofibromatosis Type 1: A Systematic Review.

Authors:  Maria Teresa García-Romero; Patricia Parkin; Irene Lara-Corrales
Journal:  Pediatr Dermatol       Date:  2015-09-04       Impact factor: 1.588

Review 8.  Segmental neurofibromatosis and cancer: report of triple malignancy in a woman with mosaic Neurofibromatosis 1 and review of neoplasms in segmental neurofibromatosis.

Authors:  Philip R Cohen
Journal:  Dermatol Online J       Date:  2016-07-15

Review 9.  Segmental neurofibromatosis (NF-5).

Authors:  E G Jung
Journal:  Neurofibromatosis       Date:  1988

10.  Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.

Authors:  Miriam J Smith; Naomi L Bowers; Michael Bulman; Carolyn Gokhale; Andrew J Wallace; Andrew T King; Simon K L Lloyd; Scott A Rutherford; Charlotte L Hammerbeck-Ward; Simon R Freeman; D Gareth Evans
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.